ReNeuron Limited   Report issue

For profit Phase 2
Founded: Guildford United Kingdom (1997)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2010
NCT01151124
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ReNeuron Limited | ReNeuron Ltd.